Where we are
We are proud to announce that Vazyme will be a contributing sponsor of the upcoming TIDES Asia: Oligonucleotide & Peptide Therapeutics, taking place from February 26 to February 28 at the Westin Miyako Kyoto in Kyoto, Japan. As a leader in the field of biomedicine, we are excited to support this prestigious event, which brings together thought leaders and innovators to share the latest advancements in oligonucleotide and peptide therapeutics.
We look forward to engaging with fellow attendees at booth 9 and showcasing our latest innovations in this dynamic and evolving industry!
Join us together
Vazyme is committed to delivering exceptional value to our customers through our cutting-edge biomedicine solutions. Our extensive portfolio includes high-quality reagents, advanced technologies, and tailored services designed to streamline research and development processes. By leveraging our expertise in oligonucleotide and peptide synthesis, we empower researchers and pharmaceutical companies to accelerate their projects and achieve their goals more efficiently. We prioritize innovation and customer collaboration, ensuring that we meet the evolving needs of the biopharmaceutical industry. Together, we can drive breakthroughs that enhance patient outcomes and advance the future of medicine.
TIDES Asia: Advancing Asia's Therapeutic Frontier
Asia's Premier Forum Accelerating Therapeutic Breakthroughs from Discovery to Market.
The exclusive Asia-Pacific gathering where leaders in oligonucleotide, peptide, mRNA, and genome editing converge to share cutting-edge strategies across discovery, development, and CMC-advancing next-generation therapeutics through collaborative innovation.